180 related articles for article (PubMed ID: 27605359)
1. Further evidence for GRIN2B mutation as the cause of severe epileptic encephalopathy.
Smigiel R; Kostrzewa G; Kosinska J; Pollak A; Stawinski P; Szmida E; Bloch M; Szymanska K; Karpinski P; Sasiadek MM; Ploski R
Am J Med Genet A; 2016 Dec; 170(12):3265-3270. PubMed ID: 27605359
[TBL] [Abstract][Full Text] [Related]
2. BRAT1 mutations present with a spectrum of clinical severity.
Srivastava S; Olson HE; Cohen JS; Gubbels CS; Lincoln S; Davis BT; Shahmirzadi L; Gupta S; Picker J; Yu TW; Miller DT; Soul JS; Poretti A; Naidu S
Am J Med Genet A; 2016 Sep; 170(9):2265-73. PubMed ID: 27282546
[TBL] [Abstract][Full Text] [Related]
3. GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders.
Ohba C; Shiina M; Tohyama J; Haginoya K; Lerman-Sagie T; Okamoto N; Blumkin L; Lev D; Mukaida S; Nozaki F; Uematsu M; Onuma A; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Kato M; Ogata K; Saitsu H; Matsumoto N
Epilepsia; 2015 Jun; 56(6):841-8. PubMed ID: 25864721
[TBL] [Abstract][Full Text] [Related]
4. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies.
Veeramah KR; Johnstone L; Karafet TM; Wolf D; Sprissler R; Salogiannis J; Barth-Maron A; Greenberg ME; Stuhlmann T; Weinert S; Jentsch TJ; Pazzi M; Restifo LL; Talwar D; Erickson RP; Hammer MF
Epilepsia; 2013 Jul; 54(7):1270-81. PubMed ID: 23647072
[TBL] [Abstract][Full Text] [Related]
5. Whole exome sequencing identifies the first STRADA point mutation in a patient with polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome (PMSE).
Bi W; Glass IA; Muzny DM; Gibbs RA; Eng CM; Yang Y; Sun A
Am J Med Genet A; 2016 Aug; 170(8):2181-5. PubMed ID: 27170158
[TBL] [Abstract][Full Text] [Related]
6. BRAT1 mutations are associated with infantile epileptic encephalopathy, mitochondrial dysfunction, and survival into childhood.
Horn D; Weschke B; Knierim E; Fischer-Zirnsak B; Stenzel W; Schuelke M; Zemojtel T
Am J Med Genet A; 2016 Sep; 170(9):2274-81. PubMed ID: 27282648
[TBL] [Abstract][Full Text] [Related]
7. Interstitial 12p13.1 deletion involving GRIN2B in three patients with intellectual disability.
Dimassi S; Andrieux J; Labalme A; Lesca G; Cordier MP; Boute O; Neut D; Edery P; Sanlaville D; Schluth-Bolard C
Am J Med Genet A; 2013 Oct; 161A(10):2564-9. PubMed ID: 23918416
[TBL] [Abstract][Full Text] [Related]
8. Novel variants in SPTAN1 without epilepsy: An expansion of the phenotype.
Gartner V; Markello TC; Macnamara E; De Biase A; Thurm A; Joseph L; Beggs A; Schmahmann JD; Berry GT; Anselm I; Boslet E; Tifft CJ; Gahl WA; Lee PR
Am J Med Genet A; 2018 Dec; 176(12):2768-2776. PubMed ID: 30548380
[TBL] [Abstract][Full Text] [Related]
9. PCDH19-related epileptic encephalopathy in a male mosaic for a truncating variant.
Thiffault I; Farrow E; Smith L; Lowry J; Zellmer L; Black B; Abdelmoity A; Miller N; Soden S; Saunders C
Am J Med Genet A; 2016 Jun; 170(6):1585-9. PubMed ID: 27016041
[TBL] [Abstract][Full Text] [Related]
10. GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy.
Lemke JR; Hendrickx R; Geider K; Laube B; Schwake M; Harvey RJ; James VM; Pepler A; Steiner I; Hörtnagel K; Neidhardt J; Ruf S; Wolff M; Bartholdi D; Caraballo R; Platzer K; Suls A; De Jonghe P; Biskup S; Weckhuysen S
Ann Neurol; 2014 Jan; 75(1):147-54. PubMed ID: 24272827
[TBL] [Abstract][Full Text] [Related]
11. Biallelic CACNA1A mutations cause early onset epileptic encephalopathy with progressive cerebral, cerebellar, and optic nerve atrophy.
Reinson K; Õiglane-Shlik E; Talvik I; Vaher U; Õunapuu A; Ennok M; Teek R; Pajusalu S; Murumets Ü; Tomberg T; Puusepp S; Piirsoo A; Reimand T; Õunap K
Am J Med Genet A; 2016 Aug; 170(8):2173-6. PubMed ID: 27250579
[TBL] [Abstract][Full Text] [Related]
12. The molecular and phenotypic spectrum of IQSEC2-related epilepsy.
Zerem A; Haginoya K; Lev D; Blumkin L; Kivity S; Linder I; Shoubridge C; Palmer EE; Field M; Boyle J; Chitayat D; Gaillard WD; Kossoff EH; Willems M; Geneviève D; Tran-Mau-Them F; Epstein O; Heyman E; Dugan S; Masurel-Paulet A; Piton A; Kleefstra T; Pfundt R; Sato R; Tzschach A; Matsumoto N; Saitsu H; Leshinsky-Silver E; Lerman-Sagie T
Epilepsia; 2016 Nov; 57(11):1858-1869. PubMed ID: 27665735
[TBL] [Abstract][Full Text] [Related]
13. Novel
Sharawat IK; Yadav J; Saini L
Neurol India; 2019; 67(2):562-563. PubMed ID: 31085877
[No Abstract] [Full Text] [Related]
14. Splice variant in ARX leading to loss of C-terminal region in a boy with intellectual disability and infantile onset developmental and epileptic encephalopathy.
Shoubridge C; Jackson M; Grinton B; Berkovic SF; Scheffer IE; Huskins S; Thomas A; Ware T
Am J Med Genet A; 2019 Aug; 179(8):1483-1490. PubMed ID: 31145546
[TBL] [Abstract][Full Text] [Related]
15. A new family with an SLC9A6 mutation expanding the phenotypic spectrum of Christianson syndrome.
Masurel-Paulet A; Piton A; Chancenotte S; Redin C; Thauvin-Robinet C; Henrenger Y; Minot D; Creppy A; Ruffier-Bourdet M; Thevenon J; Kuentz P; Lehalle D; Curie A; Blanchard G; Ghosn E; Bonnet M; Archimbaud-Devilliers M; Huet F; Perret O; Philip N; Mandel JL; Faivre L
Am J Med Genet A; 2016 Aug; 170(8):2103-10. PubMed ID: 27256868
[TBL] [Abstract][Full Text] [Related]
16. Epileptic patients with de novo STXBP1 mutations: Key clinical features based on 24 cases.
Di Meglio C; Lesca G; Villeneuve N; Lacoste C; Abidi A; Cacciagli P; Altuzarra C; Roubertie A; Afenjar A; Renaldo-Robin F; Isidor B; Gautier A; Husson M; Cances C; Metreau J; Laroche C; Chouchane M; Ville D; Marignier S; Rougeot C; Lebrun M; de Saint Martin A; Perez A; Riquet A; Badens C; Missirian C; Philip N; Chabrol B; Villard L; Milh M
Epilepsia; 2015 Dec; 56(12):1931-40. PubMed ID: 26514728
[TBL] [Abstract][Full Text] [Related]
17. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.
Endele S; Rosenberger G; Geider K; Popp B; Tamer C; Stefanova I; Milh M; Kortüm F; Fritsch A; Pientka FK; Hellenbroich Y; Kalscheuer VM; Kohlhase J; Moog U; Rappold G; Rauch A; Ropers HH; von Spiczak S; Tönnies H; Villeneuve N; Villard L; Zabel B; Zenker M; Laube B; Reis A; Wieczorek D; Van Maldergem L; Kutsche K
Nat Genet; 2010 Nov; 42(11):1021-6. PubMed ID: 20890276
[TBL] [Abstract][Full Text] [Related]
18. Genetic convergence of developmental and epileptic encephalopathies and intellectual disability.
Carvill GL; Jansen S; Lacroix A; Zemel M; Mehaffey M; De Vries P; Brunner HG; Scheffer IE; De Vries BBA; Vissers LELM; Mefford HC
Dev Med Child Neurol; 2021 Dec; 63(12):1441-1447. PubMed ID: 34247411
[TBL] [Abstract][Full Text] [Related]
19. Severe early-onset epileptic encephalopathy due to mutations in the KCNA2 gene: Expansion of the genotypic and phenotypic spectrum.
Hundallah K; Alenizi A; AlHashem A; Tabarki B
Eur J Paediatr Neurol; 2016 Jul; 20(4):657-60. PubMed ID: 27117551
[TBL] [Abstract][Full Text] [Related]
20. Two Novel Variants Affecting CDKL5 Transcript Associated with Epileptic Encephalopathy.
Neupauerová J; Štěrbová K; Vlčková M; Sebroňová V; Maříková T; Krůtová M; David S; Kršek P; Žaliová M; Seeman P; Laššuthová P
Genet Test Mol Biomarkers; 2017 Oct; 21(10):613-618. PubMed ID: 28872899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
